Holen Sie sich die Stockscreener-App
90.45
3.98%
3.46
Handel nachbörslich:
90.83
0.38
+0.42%
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
Boston Sci study shows Watchman Flx better OPTION than DOAC - BioWorld Online
Boston Scientific Completes $3.7B Acquisition of Axonics - Orange County Business Journal
Boston Scientific stock soars to all-time high of $89.33 By Investing.com - Investing.com Canada
Boston Scientific acquires Axonics - Medical Buyer
Boston Scientific reports outcomes from trial of LAAC device - Yahoo Finance
Boston Scientific to Acquire Cortex - Today's Medical Developments
Boston Scientific's WATCHMAN FLX Shows Superior Bleeding Risk Reduction in 3-Year Study | BSX Stock News - StockTitan
Boston Scientific (BSX) Completes Acquisition of Axonics - GuruFocus.com
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
Boston Scientific put volume heavy and directionally bearish - TipRanks
Boston Scientific Closes $3.7B Deal for Axonics - MPO-mag
Boston Scientific Closes Acquisition of Axonics, Inc. - Quantisnow
Boston Scientific Closes Acquisition of Axonics, Inc. – Company Announcement - Financial Times
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
SoniVie Names Axonics' Raymond Cohen as Chairman Following $3.7B Boston Scientific Deal | BSX Stock News - StockTitan
Boston Scientific Co. (NYSE:BSX) Shares Bought by Huntington National Bank - MarketBeat
Investing in Boston Scientific (NYSE:BSX) three years ago would have delivered you a 113% gain - Yahoo Finance
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Urology Devices Market to Surpass Market Valuation of USD 61.62 Billion by 2031 | SkyQuest Technology - Benzinga
Boston Scientific EVP John Sorenson sells $2.68m in stock - Investing.com
Boston Sci charges ahead with AVANT GUARD PFA trial - BioWorld Online
Boston Scientific To Present At 2024 UBS Global Healthcare Conference; Webcast At 10:15 AM ET - Nasdaq
Boston Scientific resumes enrolment in pulsed field ablation trial - Yahoo Finance
BSXBoston Scientific Corp. Latest Stock News & Market Updates - StockTitan
Boston Scientific Corporation (BSX): Among the Best Low Volatility Stocks to Invest In Now - Insider Monkey
Boston Scientific Corporation (BSX): A Hot Growth Stock to Buy According to Hedge Funds - Insider Monkey
Van ECK Associates Corp Has $5.06 Million Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
8 Hot Growth Stocks To Buy According to Hedge Funds - Insider Monkey
Boston Scientific stock soars to all-time high of $88.81 - Investing.com
We Think Boston Scientific's (NYSE:BSX) Profit Is Only A Baseline For What They Can Achieve - Yahoo Finance
Petri Dish: Boston Scientific resumes atrial fibrillation trial; Seaport hires CFO - The Business Journals
Boston Scientific CEO sells shares worth $13.8 million By Investing.com - Investing.com Canada
Boston Scientific CEO sells shares worth $13.8 million - Investing.com
Boston Scientific Corp. stock rises Thursday, still underperforms market - MarketWatch
Boston Scientific (BSX) Resumes AVANT GUARD Clinical Trial for A - GuruFocus.com
Boston Scientific resumes AVANT GUARD trial - Investing.com
Kidney Stone Management Market Forecast Report, 2024-2032Cook Group, Richard Wolf, Boston Scientific, and Dornier MedTech Actively Engaged in M&As to Increase Share - Yahoo Finance
Boston Scientific Resumes AVANT GUARD Clinical Trial - TipRanks
Boston Scientific Corp. stock rises Wednesday, still underperforms market - MarketWatch
Boston Scientific Corp. stock rises Tuesday, still underperforms market - MarketWatch
Boston Scientific to Speak at Conference - Baystreet.ca
Boston Scientific to Participate in the 2024 UBS Global Healthcare Conference – Company Announcement - Financial Times
Boston Scientific to bolster cardiac ablation portfolio with Cortex acquisition - Medical Device Network
Heritage Investors Management Corp Sells 7,684 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Johnson & Johnson, Boston Scientific least shorted stocks in S&P 500 healthcare sector for Feb-end - MSN
Boston Sci to acquire Cortex, expand AF portfolio - BioWorld Online
Boston Scientific EVP Wendy Carruthers sells $588,876 in stock - Investing.com
Boston Scientific EVP Wendy Carruthers sells $588,876 in stock By Investing.com - Investing.com UK
Are Wall Street Analysts Bullish on Boston Scientific Stock? - Nasdaq
Are Wall Street Analysts Bullish On Boston Scientific Stock? - Barchart
TD Cowen maintains Buy rating on Boston Scientific with $100 target - Investing.com
Boston Scientific continues M&A run with Cortex buy - Yahoo Finance
Boston Scientific Announces Agreement to Acquire Cortex, Inc. - Financial Times
Earnings call: Boston Scientific focuses on cardiology growth and innovation - Investing.com India
Earnings call: Boston Scientific focuses on cardiology growth and innovation By Investing.com - Investing.com Canada
Boston Scientific (BSX): A Promising Medical Stock with Strong Revenue Growth - Insider Monkey
Beyond the Balance Sheet: What SWOT Reveals About Boston Scientific Corp (BSX) - Yahoo Finance
0.17%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):